Susquehanna Portfolio Strategies »

Enliven Therapeutics shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $650k 32k 20.47
2025-06-30 $1.4M 68k 20.06